CMAB BIOPHARM
CMAB BioPharm is a Biopharmaceutical Service Firm. Suqiao Bio is a flexible, comprehensive biopharmaceutical custom development and production (CDMO) service company. Strictly in compliance with the quality standards of domestic and international pharmaceutical production management regulations, Suqiao Bio is committed to providing Chinese and global customers with a one-stop shop for preclinical and clinical drug Phase I, Phase II, and Phase III biopharmaceutical products from DNA sequences to commercial production. solution.
CMAB BIOPHARM
Industry:
Biopharma Biotechnology Manufacturing
Founded:
2017-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.cmabbio.com
Total Employee:
11+
Status:
Active
Contact:
(+86) 0512 6799 5188
Email Addresses:
[email protected]
Total Funding:
72 M USD
Technology used in webpage:
Domain Not Resolving Facebook Sharer
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical company with one approved product.
Current Employees Featured
Founder
Investors List
Cormorant Capital
Cormorant Capital investment in Series B - CMAB BioPharm
Tigermed
Tigermed investment in Series B - CMAB BioPharm
C-Bridge Capital
C-Bridge Capital investment in Series B - CMAB BioPharm
Qianhai Fund of Funds
Qianhai Fund of Funds investment in Series B - CMAB BioPharm
CD Capital
CD Capital investment in Series B - CMAB BioPharm
C-Bridge Capital
C-Bridge Capital investment in Series A - CMAB BioPharm
Qianhai Fund of Funds
Qianhai Fund of Funds investment in Series A - CMAB BioPharm
Jinqiao Capital
Jinqiao Capital investment in Series A - CMAB BioPharm
Key Employee Changes
| Date | New article |
|---|---|
| 2020-08-07 | CMAB Appoints Ms. Maggie Chen as Chief Financial Officer |
More informations about "CMAB BioPharm"
CMAB Biopharma - LinkedIn
CMAB Biopharma Inc. (CMAB), is a full-service contract development and manufacturing organization (CDMO) established in 2017, which is dedicated to providing process …See details»
CMAB BioPharm - Crunchbase Company Profile & Funding
CMAB BioPharm is a Biopharmaceutical Service Firm. Suqiao Bio is a flexible, comprehensive biopharmaceutical custom development and production (CDMO) service company.See details»
CMAB Biopharma - Ownership and Business Overview - Mergr
May 7, 2021 CMAB Biopharma CMAB BioPharma (Suzhou), Inc. Building C37, No. 188 Dong Ping Road, Suzhou, 215123 China, (+86) 0512 6799 5188 www.cmabbio.comSee details»
CMAB Biopharma: Contact Details and Business Profile
CMAB Biopharma Inc. (CMAB), is a full-service contract development and manufacturing organization (CDMO) established in 2017, which is dedicated to providing process …See details»
CMAB Biopharma - Products, Competitors, Financials, Employees ...
CMAB Biopharma is a full-service contract development and manufacturing organization (CDMO) that provides process development and manufacturing services for biologic drug substances …See details»
CMAB Biopharma Secures $34 Million Series B Financing
Apr 2, 2018 To find out more about our dynamic new CDMO, please go to the website: www.cmabbio.com. About CD Capital: CD Capital is a venture capital founded in 2013, …See details»
CMAB Biopharma Overview | SignalHire Company Profile
Organization Website: cmabbio.com : Social Links: Phone Number: 86-0512-6799-5188: CMAB Biopharma industries Biotech, Medical Research & Laboratories: Headquarters Location: No. …See details»
CMAB BioPharma (Suzhou) Inc. (苏州药明生物技术有限 …
Key Financial Ratios (For the Six Months Ended June 30) About WuXi Biologics WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end …See details»
CMAB BioPharm - Craft
CMAB BioPharm is a company that provides process development and manufacturing services for biologic products. It focuses on drug discovery, preclinical development, clinical research, …See details»
CMAB Biopharma - VentureRadar
Goodwin Biotechnology USA n/a We are a biological contract manufacturing organization (CMO) with more than two decades of experience and expertise in the development as well as …See details»
CMAB Biopharma Announces Dr. Wang Yongzhong as CEO to …
May 20, 2019 SUZHOU, China and NEW YORK, May 20, 2019 /PRNewswire/ -- CMAB Biopharma Limited. (CMAB), a strict "pure-play" contract development and manufacturing …See details»
CMAB Biopharma | LinkedIn
CMAB Biopharma | 634 Follower:innen auf LinkedIn. Exclusively focused on delivering fully integrated CDMO services for biologics | CMAB Biopharma Inc. (CMAB), is a full-service …See details»
CMAB Closes $38M Series A Financing Round - BioSpace
Jan 3, 2018 SUZHOU, China, Jan. 02, 2018 (GLOBE NEWSWIRE) -- CMAB Biopharma Inc. (CMAB), a full-service contract development and manufacturing organization (CDMO) …See details»
CMAB Biopharma - Samedan
CMAB Biopharma is a full service, pure play Contract Development and Manufacturing Organisation (CDMO), which provides bespoke solutions for mammalian cellSee details»
苏桥生物 - 新耀俱乐部管理（苏州）有限公司
苏桥生物公司网站：www.cmabbio.com公司性质：内资公司公司类型：生产自定义标签：生物大分子研发，纯粹CDMO，中美双报，CMC，GMP生产公司相关资质：欧盟第三方QP审计通过公 …See details»
CMAB Closes US$38 Million Series A Financing Round
Jan 2, 2018 Contract Manufacturing Organization Plans Rapid Expansion to Service Chinese Domestic and International Biologics Markets January 02, 2018 08:28 ET | Source: C-Bridge …See details»
祝贺苏桥生物合作伙伴信达生物新冠抗体项目美国FDA IND获批
Mar 2, 2021 详情请访问公司官方网站www.cmabbio.com。 苏桥生物（苏州）有限公司. 地址：苏州工业园区东平街188号C37&C29. 电话：0512-6799 5177. 商务联系方式：[email protected]. 媒体联络人：[email protected] — END — 推荐阅读. 阿斯利康王磊：新时代医药企业的破局之道（附: 视频）See details»
Employees, Org Chart, News, Posts, Hirings on Oct 2024
CMAB Biopharma Inc. (CMAB), is a full-service contract development and manufacturing organization (CDMO) established in 2017, which is dedicated to providing process …See details»
CMAB Biopharma Announces Dr. Wang Yongzhong as CEO to
May 20, 2019 SUZHOU, China and NEW YORK, May 20, 2019 /PRNewswire/ -- CMAB Biopharma Limited. (CMAB), a strict “pure-play” contract development and manufacturing …See details»
CMAB Biopharma and BJ Bioscience Establish an Exclusive …
Oct 11, 2019 Under this agreement, CMAB will provide a full range of CMC research and manufacturing services that meet the IND application requirements of both China and the …See details»